Page 3 - Tim Brons News Today

CDMO earnings call for the period ending December 31, 2021.

CDMO earnings call for the period ending December 31, 2021.

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

/PRNewswire/ -- Vivace Therapeutics, Inc., a small molecule discovery and development company developing first-in-class therapies targeting the Hippo pathway,...

/PRNewswire/ -- Vivace Therapeutics, Inc., a small molecule discovery and development company developing first-in-class therapies targeting the Hippo pathway,...

CDMO earnings call for the period ending October 31, 2021.

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

/PRNewswire/ -- Antiva Biosciences, a biopharmaceutical company developing novel, topical therapeutics for the treatment of pre-cancerous lesions caused by...

Operator Good day, ladies and gentlemen and welcome to the Avid Bioservices Fourth Quarter Fiscal 2021 Financial Results Conference Call. At this time, all participants are in a listen-only mode. Later we will conduct a question-and-answer session and instructions will follow at that time. As a reminder, this conference call may be recorded. I would now like to hand the conference over to Tim Brons of Avids Investor Relations Group. Please go ahead. Tim Brons -- Executive Vice President, Vida ...

Operator Good day, ladies and gentlemen. And welcome to the Avid Bioservices Third Quarter Fiscal 2021 Financial Results Conference Call. [Operator Instructions] As a reminder, this conference may be recorded. I would now turn the call over to Mr. Tim Brons of Avids Investor Relations Group. Please go ahead, sir. Tim Brons -- Investor Relations Thank you. Good afternoon and thank you for joining us. On todays call, we have Nick Green, President and CEO; Dan Hart, Chief Financial Officer; and T...